The COVID-19 crisis has been especially demanding for frontline healthcare professionals like pulmonologists. We are entering a phase now where hospitals start up more of their activities and more patients are again being tested in the lung function departments. Not only will the labs progressively start ramping up the traditional patients, but also the COVID-19 survivors require follow-up that includes regular lung function testing.

The coming months will remain challenging with extra hygienic measures, careful patient selection and support on the COVID departments.

Response to covid-19

At ArtiQ we want to contribute where we can. Our software supports pulmonologists by automating reporting of pulmonary function tests. It automates protocoling and uses AI to help detect lung diseases, which could help to come to a final diagnosis with fewer tests. In this way, we could support the optimal use of the available testing capacity and help pulmonologists spend their time more with patients, less with administrative work.

We want pulmonologists to spend their time with their patients, not on report writing. This is something we strongly believe in and is even more important today.” said Marko Topalovic, CEO of ArtiQ

To ensure hospitals can benefit to the fullest, we are not charging any licensing fees for the ArtiQ.PFT software till September. Current customers will not be charged for this period or will have their license period extended. We are working with our local partners, such as Acertys, to work out ways to quickly enroll new hospitals who want to make use of the ArtiQ.PFT software in this period.

Contact us to discuss how we can support your hospital.

Close Menu
COVID-19: We are not charging licensing fees for our ArtiQ.PFT software till September, for both existing and new customers. Discover morehere